Thymosin α1 inserts N terminus into model membranes assuming a helical conformation

Bibliography

• Goldstein AL, Guha A, Zatz MM, et al. Purification and Biological Activity of Thymosin, a Hormone of the Thymus Gland. Proc Natl Acad Sci USA 1972;69(7):1800-3
   PubMed Web of Science ®Google Scholar
• Low TL, Thurman GB, McAdoo M, et al. The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus. J Biol Chem 1979;254(3):981-6
   PubMed Web of Science ®Google Scholar
• Low TL, Goldstein AL. The chemistry and biology of thymosin. II. Amino acid sequence analysis of thymosin alpha1 and polypeptide beta1. J Biol Chem 1979;254(3):987-95
   PubMed Web of Science ®Google Scholar
• Sarandeses CS, Covelo G, Díaz-Jullien C, et al. Prothymosin alpha is processed to thymosin alpha 1 and thymosin alpha 11 by a lysosomal asparaginyl endopeptidase. J Biol Chem 2003;278(15):13286-93
   PubMed Web of Science ®Google Scholar
• Franco FJ, Diaz C, Barcia M, et al. Thymosin alpha 1 is a native peptide in several tissues. Biochim Biophys Acta 1992;1120(1):43-8
   PubMed Web of Science ®Google Scholar
• Chen JM, Dando PM, Rawlings ND, et al. Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase. J Biol Chem 1997;272(12):8090-8
   PubMed Web of Science ®Google Scholar
• Manrow RE, Sburlati AR, Hanover JA, et al. Nuclear targeting of prothymosin alpha. J Biol Chem 1991;266(6):3916-24
   PubMed Web of Science ®Google Scholar
• Eschenfeldt WH, Manrow RE, Krug MS, et al. Isolation and partial sequencing of the human prothymosin alpha gene family. Evidence against export of the gene products. J Biol Chem 1989;264(13):7546-55
   PubMed Web of Science ®Google Scholar
• Iino S, Toyota J, Kumada H, et al. The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial. J Viral Hepatitis 2005;12:300-6
   PubMed Web of Science ®Google Scholar
• You J, Zhuang L, Cheng HY, et al. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study. World J. Gastroenterol 2006;12:6715-21
   Web of Science ®Google Scholar
• Andreone P, Cursaro C, Gramenzi A, et al. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C. J Viral Hepatitis 2001;8:194-201
   PubMed Web of Science ®Google Scholar
• Kullavanuava P, Treeprasertsuk S, Thong-Ngam D, et al. The combined treatment of interferon alpha-2a and thymosin alpha 1 for chronic hepatitis C: the 48 weeks end of treatment results. J Med Assoc Thai 2001;84:462-8
   Google Scholar
• Carraro G, Naso A, Montomoli E, et al. Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study. Vaccine 2012;30:1170-80
   PubMed Web of Science ®Google Scholar
• Goldstein AL. From lab to bedside: emerging clinical applications of thymosin alpha 1. Expert Opin Biol Ther 2009;9:593-608
   PubMed Web of Science ®Google Scholar
• Maio M, Mackiewicz A, Testori A, et al. Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma. J Clin Oncol 2010;28:1780-7
   PubMed Web of Science ®Google Scholar
• Billich A. Thymosin alpha1 sciclone pharmaceuticals. Curr Opin Investig Drugs 2002;3(5):698-707
   PubMedGoogle Scholar
• Romani L, Moretti S, Fallarino F, et al. Jack of all trades: thymosin α1 and its pleiotropy. Ann N Y Acad Sci 2012;1269:1-6
   PubMed Web of Science ®Google Scholar
• Garaci E, Pica F, Serafino A, et al. Thymosin α1 and cancer: action on immune effector and tumor target cells. Ann N Y Acad Sci 2012;1269:26-33
   PubMed Web of Science ®Google Scholar
• Serafino A, Pica F, Andreola F, et al. Thymosin α1 activates complement receptor-mediated phagocytosis in human monocyte-derived macrophages. J Innate Immun 2014;6(1):72-88
   PubMed Web of Science ®Google Scholar
• Giuliani C, Napolitano G, Mastino A, et al. Thymosin-alpha1 regulates MHC class I expression in FRTL-5 cells at transcriptional level. Eur J Immunol 2000;30:778-86
   PubMed Web of Science ®Google Scholar
• Knutsen AP, Freeman JJ, Mueller KR, et al. Thymosin-alpha1 stimulates maturation of CD34+ stem cells into CD3+4+ cells in an in vitro thymic epithelia organ coculture model. Int J Immunopharmacol 1999;21:15-26
   PubMed Web of Science ®Google Scholar
• Romani L, Bistoni F, Gaziano R, et al. Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling. Blood 2004;103:4232-9
   PubMed Web of Science ®Google Scholar
• Zhang P, Chan J, Dragoi AM, et al. Activation of IKK by thymosinα1 requires the TRAF6 signaling pathway. EMBO Rep 2005;6:531-7
   PubMed Web of Science ®Google Scholar
• Lao X, Liu M, Chen J, et al. A tumor-penetrating peptide modification enhances the antitumor activity of thymosin alpha 1. PLoS One 2013;8(8):e72242
   PubMedGoogle Scholar
• Zetter BR. On target with tumor blood vessel markers. Nat Biotechnol 1997;15(12):1243-4
   PubMed Web of Science ®Google Scholar
• Grottesi A, Sette M, Palamara T, et al. The conformation of peptide thymosin alpha 1 in solution and in a membrane like environment by circular dichroism and NMR spectroscopy. A possible model for its interaction with the lymphocyte membrane. Peptides 1998;19:1731-8
   PubMed Web of Science ®Google Scholar
• Elizondo-Riojas MA, Chamow SM, Tuthill CW, et al. NMR structure of human thymosin alpha-1. Biochem Biophys Res Commun 2011;416:356-61
   PubMed Web of Science ®Google Scholar
• Chupin V, Killian JA, Breg J, et al. PHOE signal peptide inserts into micelles as a dynamic helix-break-helix structure which is modulated by the environment. A two-dimensional NMR study. Biochemistry 1995;34:11617-24
   PubMed Web of Science ®Google Scholar
• Leichtling KD, Serrate SA, Sztein MB. Thymosin α1 modulates the expression of high-affinity IL-2 receptor on normal human lymphocytes. Int J Immunopharmacology 1990;1:19-29
   Google Scholar
• Macquarie F, Baleux F, Huynh-Dinh TD, et al. Proton NMR conformational study of an Annexin I fragment: influence of a phospholipidic micellar environment. Biochemistry 1993;32:7244-54
   PubMed Web of Science ®Google Scholar
• Wang Z, Jones DJ, Rizo J, et al. Membrane bound conformation of a signal peptide: a transferred nuclear Overhauser effect analysis. Biochemistry 1993;32:13991-9
   PubMed Web of Science ®Google Scholar
• Marion D, Wuthrich K. Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of (1)H-(1)H spin-spin coupling constants in proteins. Biochem Biophys Res Commun 1983;113:967-74
   PubMed Web of Science ®Google Scholar
• Bax A, Davis DG. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J Magn Reson 1985;65:355-60
   Web of Science ®Google Scholar
• Braunschweiler L, Ernst RR. Coherence transfer by isotropic mixing: application to proton correlation spectroscopy. J Magn Reson 1983;53:521-8
   Web of Science ®Google Scholar
• Jeener J, Meier BH, Bachmann P, et al. Investigation of exchange processes by two-dimensional NMR spectroscopy. J Chem Phys 1979;71:4546-53
   Web of Science ®Google Scholar
• Bodenhausen G, Reuben DJ. Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy. Chem Phys Lett 1980;69:185-9
   Web of Science ®Google Scholar
• Grzesiek S, Bax A. Correlating backbone amide and side chain resonances in larger proteins by multiple relayed triple resonance NMR. J Am Chem Soc 1992;114:6291-3
   Web of Science ®Google Scholar
• Brunger AT. XPLOR Manual Version 3.1. Yale University Press; New Haven, CT: 1993
   Google Scholar
• Omichinski JG, Pedone PV, Felsenfeld G, et al. The solution structure of a specific GAGA factor-DNA complex reveals a modular binding mode. Nature Struct Biol 1997;4:122-32
   PubMedGoogle Scholar
• Laskowski RA, MacArthur MW, Moss DS, et al. PROCHECK - a program to check the stereochemical quality of protein structures. J App Cryst 1993;26:283-91
   Web of Science ®Google Scholar
• Morris KF, Johnson CSJr. Diffusion-ordered two-dimensional nuclear magnetic resonance spectroscopy. J Am Chem Soc 1992;114:3139-41
   Web of Science ®Google Scholar
• Cohen Y, Avram L, Frish L. Diffusion NMR. Spectroscopy in Supramolecular and Combinatorial Chemistry: an Old Parameter-New Insights. Angew Chem Int Ed 2005;44:520-54
   PubMed Web of Science ®Google Scholar
• Wishart DS, Sykes BD, Richards FM. The Chemical Shift Index: a Fast and Simple Method for the Assignment of Protein Secondary Structure through NMR Spectroscopy. J Mol Biol 1991;222:311-33
   PubMed Web of Science ®Google Scholar
• Wüthrich K. NMR of Proteins and Nucleic Acids. John Wiley & Sons; New York: 1986
   Google Scholar
• Toniolo C, Polese A, Formaggio F, et al. Circular Dichroism Spectrum of a Peptide 310-Helix. J Am Chem Soc 1996;118:2744-5
   Web of Science ®Google Scholar
• Moretto A, Crisma M, Formaggio F, et al. Slow tert-butyl ester acidolysis and peptide 310-helix to α-Helix transition in HFIP solution. Biopolymers 2007;88(2):233-8
   PubMed Web of Science ®Google Scholar
• Sargent DF, Schwyzer R. Membrane lipid phase as catalyst for peptide receptor interactions. Proc Natl Acad Sci USA 1986;83:5774-8
   PubMed Web of Science ®Google Scholar
• Jencks WP. Binding energy, specificity, and enzymic catalysis: the circe effect. Adv Enzymol Relat Areas Mol Biol 1975;43:219-410
   PubMedGoogle Scholar